Placental clearance/synthesis of neurobiomarkers GFAP and UCH-L1 in healthy term neonates and those with moderate-severe neonatal encephalopathy

Neonatal encephalopathy (NE) is associated with substantial morbidity and mortality and affects around 1.5/1000 live term births. Predicting the severity and outcome of neonates with NE is therefore vital in order to provide the best care for neonates with NE, and a biochemical marker obtained at birth would therefore be useful to bolster the current scoring system. In this episode, Geoff Marsh speaks to Early Career Investigator Dr. Imran Nazir Mir, from the University of Texas, Southwestern Medical Center. He's just published a paper testing the utility of two potential candidate proteins for determining the presence and severity of hypoxic NE, and to understand where these molecules are synthesized and cleared.

Hosted on Acast. See acast.com/privacy for more information.

More from Pediatric Research Podcast

  1. 11:15What's hot in Endocrinology? Apr 24, 2024
  2. 13:18Conversation With Pediatric Researchers Cynthia Bearer and Eleanor MolloyMar 22, 2024
  3. 13:43Conversation with Linda de VriesFeb 06, 2024
  4. 13:46Global climate change: the defining issue of our time for our children’s healthJan 16, 2024
  5. 13:24Predicting functional and quality-of-life outcomes following pediatric sepsis.Nov 29, 2023
  6. 17:42Conversation with Dr. Maximo VentoNov 20, 2023
  7. 13:01The association of placental pathology and neurodevelopmental outcomes in patients with neonatal encephalopathyNov 02, 2023
  8. 11:59Do Bayley trajectories predict school-readiness better than single assessments in formerly very preterm infants?Oct 23, 2023
  9. 11:19Novel metrics to characterise the temporal lobe of very preterm infants.Sep 11, 2023
  10. 12:13Trends in fetal and neonatal outcomes during the COVID-19 pandemicAug 23, 2023